Autosomal Dominant Spinocerebellar Ataxias: An Asian Perspective

Canadian Journal of Neurological Sciences

Volumn 30, Issue 4, 2003, Pages 361-367

  Tan, E K ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ASIAN; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL DOMINANT INHERITANCE; DENTATORUBROPALLIDOLUYSIAN ATROPHY; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENETIC COUNSELING; GENOTYPE; HUMAN; LEGAL ASPECT; MEDICAL ETHICS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; SOCIAL ASPECT; SPINOCEREBELLAR DEGENERATION;

EID: 0346099507     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100003085     Document Type: Review

References (74)

1. Tan EK, Ashizawa T. Genetic testing in spinocerebellar ataxia: defining a clinical role. Arch Neurol 2001;58:191-195.
2. Wells RD, Warren ST. Genetic instabilities and hereditary neurological diseases. Academic Press 1998.
3. Subramony SH, Filla A. Autosomal dominant spinocerebellar ataxias ad infinitum? Neurology 2001;56:287-289.
4. Klockgether T, Wullner U, Spauschus A, Evert B. The molecular biology of the autosomal dominant cerebellar ataxias. Mov Disord 2000;15:604-612.
5. Holmes G. An attempt to classify cerebellar disease, with a note on Marie's hereditary ataxia. Brain 1907;30:545-567.
6. Harding AE. Clinical features and classification of inherited ataxias. Adv Neurol 1993;61:1-14.
7. Orr HT, Chung M, Banfi S, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 1993;4:221-226.
8. Pulst SM, Nechiporuk A, Nechiporuk T, et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 1996;14:269-276.
9. Imbert G, Saudou F, Yvert G, et al Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet 1996;14:285-291.
10. Geschwind DH, Perlman S, Figueroa CP, Treiman LJ, Pulst SM. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet 1997;60:842-850.
11. Kawaguchi Y, Okamoto T, Taniwaki M, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 1994;8:221-228.
12. Flanigan K, Gardner K, Alderson K, et al. Autosomal dominant spinocerebellar ataxia with sensory axonal neuropathy (SCA4): clinical description and genetic localization to chromosome 16q22.1. Am J Hum Genet 1996;59:392-399.
13. Ranum LP, Schut LJ, Lundgren JK, Orr HT, Livingston DM. Spinocerebellar ataxia type 5 in a family descended from the grandparents of President Lincoln maps to chromosome 11. Nat Genet 1994;8:280-284.
14. Zhuchenko O, Bailey J, Bonnen P, et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha (1A)-voltage-dependent calcium channel. Nat Genet 1997;15:62-69.
15. David G, Abbas N, Stevanin G, et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet 1997;17:65-70.
16. Koob MD, Moseley ML, Schut LJ, et al. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat Genet 1999;21:379-384.
17. Matsuura T, Yamagata T, Burgess DL, et al. Large expansion of ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet 2000;26:191-194.
18. Worth PF, Giunti P, Gardner-Thorpe C, et al. Autosomal dominant cerebellar ataxia type III: linkage in a large British family to a 7.6cM region on chromosome 15q14-21.3. Am J Hum Genet 1999;65:420-426.
19. Holmes SE, O'Hearn EE, Mcinnis MG, et al. Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12. Nat Genet 1999;23:391-392.
20. Herman-Bert A, Stevanin G, Netter J-C, et al. Mapping of spinocerebellar ataxia 13 to chromosome 19q13.3-q13.4 in a family with autosomal dominant cerebellar ataxia and mental retardation. Am J Hum Genet 2000;67:229-235.
21. Yamashita I, Sasaki H, Yabe I, et al. A novel locus for dominant cerebellar ataxia (SCA14) maps to a 10.2-cM interval flanked by D19S206 and D19S605 on chromosome 19q13.4-qter. Ann Neurol 2000;48:156-163.
22. Miyoshi Y, Yamada T, Tanimura M, et al. A novel autosomal dominant spinocerebellar ataxia (SCA 16) linked to chromosome 8q22.1-24.1. Neurology 2001;57:96-100.
23. Nakamura K, Jeong SY, Uchihara T, et al. SCA 17, a novel autosomal dominant cerebellar atxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 2001;10:1441-1448.
24. Browne DL, Gancher ST, Nutt JG, et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 1994;8:136-140.
25. Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996;87:543-552.
26. Matsuura T, Ranum LP, Volpini V, et al. Spinocerebellar ataxia type 10 is rare in populations other than Mexicans. Neurology 2002;58:983-984.
27. Higgins JJ, Nee LE, Vasconcelos O, et al. Mutations in American families with spinocerebellar ataxia (SCA) type 3: SCA3 is allelic to Machado-Joseph disease. Neurology 1996;46:208-213.
28. Pareyson D, Gellera C, Castellotti B, et al. Clinical and molecular studies of 73 Italian families with autosomal dominant cerebellar ataxia type I: SCA1 and SCA2 are the most common genotypes. J Neurol 1999;246:389-393.
29. Filla A, De Michele G, Santoro L, et al. Spinocerebellar ataxia type 2 in southern Italy: a clinical and molecular study of 30 families. J Neurol 1999;246:467-471.
30. Schols L, Amoiridis G, Epplen JT, et al. Relations between genotype and phenotype in German patients with the Machado-Joseph disease mutation. J Neurol Neurosurg Psychiatry 1996;61:466-470.
31. Leggo J, Dalton A, Morrison PJ, et al. Analysis of spinocerebellar ataxia types 1, 2, 3, and 6, dentatorubral-pallidoluysian atrophy, and Friedreich's ataxia genes in spinocerebellar ataxia patients in the UK. J Med Genet 1997;34:982-985.
32. Mori M, Adachi Y, Kusumi M, Nakashima K. A genetic epidemiological study of spinocerebellar ataxias in Tottori prefecture, Japan. Neuroepidemiology 2001;20:144-149.
33. Mori M, Adachi Y, Kusumi M, Nakashima K. Spinocerebellar ataxia type 6: founder effect in Western Japan. J Neurol Sci 2001;185:43-47.
34. Onodera Y, Aoki M, Tsuda T, et al. High prevalence of spinocerebellar ataxia type 1 (SCA1) in an isolated region of Japan. J Neurol Sci 2000;178:153-158.
35. Yamashita I, Sasaki H, Yabe I, et al. A novel locus for dominant cerebellar ataxia (SCA14) maps to a 10.2-cM interval flanked by D19S206 and D19S605 on chromosome 19q13.4-qter. Ann Neurol 2000;48:156-163.
36. Sasaki H, Yabe I, Yamashita I, Tashiro K. Prevalence of triplet repeat expansion in ataxia patients from Hokkaido, the northernmost island of Japan. J Neurol Sci 2000;175:45-51.
37. Ikeda Y, Shizuka M, Watanabe M, Okamoto K, Shoji M. Molecular and clinical analyses of spinocerebellar ataxia type 8 in Japan. Neurology 2000;54:950-955.
38. Seto M, Tsujihata M. Cluster of Machado-Joseph disease in a small rural town near Nagasaki City, Japan: clinical and genetic studies of two families. J Neurol 1999;246:405-407.
39. Shan DE, Soong BW, Sun CM, et al. Spinocerebellar ataxia type 2 presenting as familial levodopa-responsive parkinsonism. Ann Neurol 2001;50:812-815.
40. Soong BW, Lu YC, Choo KB, Lee HY. Frequency analysis of autosomal dominant cerebellar ataxias in Taiwanese patients and clinical and molecular characterization of spinocerebellar ataxia type 6. Arch Neurol 2001;58:1105-1109.
41. Zhou YX, Qiao WH, Gu WH, et al. Spinocerebellar ataxia type 1 in China: molecular analysis and genotype-phenotype correlation in 5 families. Arch Neurol 2001;58:789-794.
42. Gu W, Wang Y, Liu X, et al. Molecular and clinical study of spinocerebellar ataxia type 7 in Chinese kindreds. Arch Neurol 2000;57:1513-1518.
43. Tang B, Liu C, Shen L, et al. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds. Arch Neurol 2000;57:540-554.
44. Cai T, Yu P, Chen X, Lopa M. Trinucleotide repeat expansion of spinocerebellar ataxia (SCA1) found in a Chinese family. Chin Med J (Engl) 1998;111:160-162.
45. Tang B, Wang D, Xia J. SCA1, SCA2, MJD/SCA3 (CAG)n mutation detection and analysis in patients with hereditary spinocerebellar ataxia from Chinese families. Zhonghua Yi Xue Za Zhi 1997;77:819-822.
46. Zhou YX, Wang GX, Tang BS, et al. Spinocerebellar ataxia type 2 in China: molecular analysis and genotype-phenotype correlation in nine families. Neurology 1998;51:595-598.
47. Hsieh M, Tsai HF, Lu TM, et al. Studies of the CAG repeat in the Machado-Joseph disease gene in Taiwan. Hum Genet 1997;100:155-162.
48. Srivastava AK, Choudhry S, Gopinath MS, et al. Molecular and clinical correlation in five Indian families with spinocerebellar ataxia 12. Ann Neurol 2001;50:796-800.
49. Gangopadhyay PK, Ghosh B, Roy T, et al. Spinocerebellar ataxia - type 6. J Assoc Physicians India 2001;49:658-659.
50. Fujigasaki H, Verma IC, Camuzat A, et al. SCA12 is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian family. Ann Neurol 2001;49:117-121.
51. Basu P, Chattopadhyay B, Gangopadhaya PK, et al. Analysis of CAG repeats in SCA1, SCA2, SCA3, SCA6, SCA7 and DRPLA loci in spinocerebellar ataxia patients and distribution of CAG repeats at the SCA1, SCA2 and SCA6 loci in nine ethnic populations of eastern India. Hum Genet 2000;106:597-604.
52. Saleem Q, Choudhry S, Mukerji M, et al. Molecular analysis of autosomal dominant hereditary ataxias in the Indian population: high frequency of SCA2 and evidence for a common founder mutation. Hum Genet 2000;106:179-187.
53. Pang J, Allotey R, Wadia N, et al. A common disease haplotype segregating in spinocerebellar ataxia 2 (SCA2) pedigrees of diverse ethnic origin. Eur J Hum Genet 1999;7(7):841-845.
54. Wadia N, Pang J, Desai J, et al. A clinicogenetic analysis of six Indian spinocerebellar ataxia (SCA2) pedigrees. The significance of slow saccades in diagnosis. Brain 1998;121(Pt 12):2341-2355.
55. Giunti P, Sweeney MG, Harding AE. Detection of the Machado-Joseph disease/spinocerebellar ataxia three trinucleotide repeat expansion in families with autosomal dominant motor disorders, including the Drew family of Walworth. Brain 1995;118(Pt 5):1077-1085.
56. Koh SH, Kim HT, Kim SH, et al. Spinocerebellar ataxia type 6 and episodic ataxia type 2 in a Korean family. J Korean Med Sci 2001;16:809-813.
57. Kim JM, Shin S, Kim JY, et al. Spinocerebellar ataxia type 2 in seven Korean families: CAG trinucleotide expansion and clinical characteristics. J Korean Med Sci 1999;14:659-664.
58. Stevanin G, David G, Durr A, et al. Multiple origins of the spinocerebellar ataxia 7 (SCA7) mutation revealed by linkage disequilibrium studies with closely flanking markers, including an intragenic polymorphism (G3145TG/A3145TG). Eur J Hum Genet 1999;7:889-896.
59. Jin DK, Oh MR, Song SM, et al. Frequency of spinocerebellar ataxia types 1,2,3,6,7 and dentatorubral pallidoluysian atrophy mutations in Korean patients with spinocerebellar ataxia. J Neurol 1999;246:207-210.
60. Tan EK, Law HY, Zhao Y, et al. Spinocerebellar ataxias in Singapore: predictive features of a positive DNA test? Eur Neurol 2000;44:168-171.
61. Monckton DG, Cayuela ML, Gould FK, et al. Very large (CAG)(n) DNA repeat expansions in the sperm of two spinocerebellar ataxia type 7 males. Hum Mol Genet 1999;8:2473-2478.
62. Zoghbi HY, Orr HT. Polyglutamine diseases: protein cleavage and aggregation. Curr Opin Neurobiol 1999;9:566-570.
63. Cummings CJ, Orr HT, Zoghbi HY. Progress in pathogenesis of spinocerebellar ataxia type 1. Philos Trans R Soc Lond 1999;354:1079-1081.
64. Burright EN, Davidson JD, Duvick LA, Koshy B, Zoghbi HY. Identification of a self-associated region within the SCA 1 gene product, ataxin-1. Hum Mol Genet 1997;6:513-518.
65. Holmberg M, Duyckaerts C, Durr A, et al. Spinocerebellar ataxia type 7 (SCA 7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet 1998;7:913-918.
66. Paulson HL, Perez MK, Trottier Y, et al. Intranuclear inclusions of expanded glutamine protein in spinocerebellar ataxia type 3. Neuron 1997;19:333-344.
67. Skinner PJ, Koshy BT, Cummings CJ, et al. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 1997;389:971-974.
68. Cummings CJ, Mancini MA, Antalffy B, et al. Chaperone suppression of aggregation and altered subcellular proteosome localization imply protein misfolding in SCA 1. Nat Genet 1998;19:148-154.
69. Chai Y, Koppenhafer SL, Shoesmith SJ, Perez MK, Paulson HL. Evidence for proteosome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine in vitro. Hum Mol Genet 1999;8:673-682.
70. Klement IA, Skinner PJ, Kaytor MD, et al. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA 1 transgenic mice. Cell 1998;95:41-53.
71. Tan EK, Lim SH, Chan LL, Wong MC, Tan KP. X-linked adrenoleukodystrophy: spinocerebellar variant. Clin Neurol Neurosurg 1999;101:137-140.
72. Guidelines for the molecular genetics predictive test in Huntington's disease. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's chorea. Neurology 1994;44:1533-1536.
73. Botez MI, Botez-Marquard T, Mayer P, et al. The treatment of spinocerebellar ataxias: facts and hypotheses. Med Hypotheses 1998;51:381-384.
74. Gasser T, Bressman S, Durr A, et al. State of the art review: molecular diagnosis of inherited movement disorders. Movement Disorders Society task force on molecular diagnosis. Mov Disord. 2003;18(1):3-18.